Application‑based Cultivated Oyster Mushrooms segmentation isolates five principal end‑use categories. Food & beverage uses the largest share—approximately 55 % of market value—driven by incorporation into ready‑to‑eat meals, sauces, and gourmet dishes where texture and flavor are critical. Nutraceutical applications, accounting for about 25 %, involve mushroom powders and extracts marketed for immune support, antioxidant capacity, and dietary fiber enrichment. The pharmaceutical segment, roughly 10 %, focuses on bioactive compounds such as lovastatin and ergothioneine, supporting clinical research and specialty drug development. Animal feed consumes near 7 % of production, leveraging the high protein and mineral content to improve livestock growth rates. Finally, the cosmetics niche, at about 3 %, utilizes mushroom‑derived polysaccharides for anti‑aging and skin‑brightening formulations. Each application contributes distinct margin structures and regulatory considerations, collectively shaping the overall market dynamics.